MedPath

Effect of Hyaluronic Acid and Single Dose Corticosteroid Injection to Improve Wound Healing in Controlled Diabetic Patients Post Tooth Extraction.

Phase 4
Completed
Conditions
Diabetes Mellitus
Wound Healing Delayed
Interventions
Drug: Hyaluronic Acid (HA)
Drug: Corticosteroid Injection
Registration Number
NCT06637384
Lead Sponsor
Rimsha Rasheed
Brief Summary

The goal of this clinical trial is to learn if hyaluronic acid and corticosteroid improves wound healing in diabetic patients after oral extraction.

Detailed Description

After sample size estimation via Open Epi of 128, randomized clinical trial was performed on the patients from Oral and Maxillofacial Surgery Department in Madinah Teaching Hospital, Faisalabad. Patients were divided into three groups. Group 1 was subjected as control group, Group 2 was treated post extraction with 0.2 % Hyaluronic acid (Gengigel Gingival Gel 20ml, Ricerfarma, Milan, Italy) and Group 3 was treated with single dose Hy-Cortisone Injection 250 mg (Generic name: Hydrocortisone Sodium Succinate, Cirin Pharmaceuticals Pakistan) intramuscularly after extraction. Wound healing was assessed through Landry Healing Index. One-way ANOVA test was applied for comparative analysis and Post Hoc Tuckey's test was applied for pairwise comparisons between the groups

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
128
Inclusion Criteria
  • • Controlled diabetic patients who had random blood glucose levels of 80 to 130 mg/dl, according to World Health Organization.

    • Age was defined from 25-55, irrespective of the gender.
    • Tooth extractions in maxilla or mandible without the presence of an acute infection or compromised periodontal state.
Exclusion Criteria
  • • Patients who declined to participate.

    • Patients below the age of 25 and above the age of 55.
    • Patients with uncontrolled diabetes mellitus (blood sugar levels high than the defined range)
    • Patients with history of adverse effects to local anesthetics or who are currently taking corticosteroids.
    • Patients with unmaintained oral hygiene and smoking habits.
    • Confirmation of any chronic illness, including those with hypertension or cardiac disorders.
    • Patients who have undergone any recent major surgical procedure.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 2Hyaluronic Acid (HA)Patients treated with 0.2 % Hyaluronic acid (Gengigel Gingival Gel 20ml, Ricerfarma, Milan, Italy) applied in extraction socket.
Group 3Corticosteroid InjectionThe extraction socket of these patients were treated with a single dose of Hy-Cortisone Injection 250 mg (Generic name: Hydrocortisone Sodium Succinate, Cirin Pharmaceuticals, Pakistan).
Primary Outcome Measures
NameTimeMethod
Wound healing6 days

The wound healing after follow was assessed via Landry Healing Index. This index had five grades very poor (1), poor (2), good (3), very good (4) and excellent (5). Each grade further had five parameters that included tissue color, response to palpation, granulation tissue, incision margin and suppuration.

Tissue color was further categorized into \>50% of red gingiva for grade 1 and 2. For grade 3 tissue color was specified as 25-50% of red gingiva. Less than 25% for grade 4 and all pink tissues for grade 5.Response to palpation was assessed as yes for grade 1 and 2, and no for the remaining three grades. The presence of granulation tissue was examined as yes for grade 1 and 2, and no for grade 3, 4 and 5. If the Incision margin was not epithelialized with loss of epithelium beyond incision margin it was considered grade 1. Incision margin not epithelialized with connective tissue exposure was marked as grade 2. For grade 3, 4 and 5, the connective tissue exposure was nil.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Oral and Maxillofacial Surgery, Madinah Teaching Hospital, Faisalabad

🇵🇰

Faisalabad, Punjab, Pakistan

© Copyright 2025. All Rights Reserved by MedPath